Top Biotechnology companies in Netherlands by EBITDA

This ranking features the top 6 Biotechnology companies in Netherlands ranked by EBITDA, totaling a EBITDA of USD -426.98 M, for July 26, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue Revenue Year-on-Year (YoY) growth Operating Income EBIT Free Cash Flow Dividend Yield Free Cash Flow Yield Total Assets Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

Frequently Asked Questions

Which Biotechnology company in Netherlands has the highest EBITDA ?

The Biotechnology company in Netherlands with the highest EBITDA is Qiagen N.V. (NYSE: QGEN) at USD 372.10 M.

Which Biotechnology company in Netherlands has the lowest EBITDA ?

The Biotechnology company in Netherlands with the lowest EBITDA is Merus N.V. (NasdaqGM: MRUS) at USD -336.40 M.

What are the top 10 Biotechnology companies in Netherlands by EBITDA ?

The top 10 Biotechnology companies in Netherlands by EBITDA are Qiagen N.V., LAVA Therapeutics N.V., ProQR Therapeutics N.V., uniQure N.V., NewAmsterdam Pharma Company N.V. and Merus N.V..

What are the bottom 10 Biotechnology companies in Netherlands by EBITDA ?

The bottom 10 Biotechnology companies in Netherlands by EBITDA are Merus N.V., NewAmsterdam Pharma Company N.V., uniQure N.V., ProQR Therapeutics N.V., LAVA Therapeutics N.V. and Qiagen N.V..